Covid-19 Impact on Ketorolac Market , Global Research Reports 2020-2021

1.2 Market Segmentation

1.3 Research Objectives

1.4 Research Methodology

1.4.1 Research Process

1.4.2 Data Triangulation

1.4.3 Research Approach

1.4.4 Base Year

1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth

1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections

1.5.2 Covid-19 Impact: Commodity Prices Indices

1.5.3 Covid-19 Impact: Global Major Government Policy

1.6 The Covid-19 Impact on Ketorolac Industry

1.7 COVID-19 Impact: Ketorolac Market Trends

2 Global Ketorolac Quarterly Market Size Analysis

2.1 Ketorolac Business Impact Assessment - COVID-19

2.1.1 Global Ketorolac Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026

2.1.2 Global Ketorolac Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026

2.2 Global Ketorolac Quarterly Market Size 2020-2021

2.3 COVID-19-Driven Market Dynamics and Factor Analysis

2.3.1 Drivers

2.3.2 Restraints

2.3.3 Opportunities

2.3.4 Challenges

3 Quarterly Competitive Assessment, 2020

3.1 Global Ketorolac Quarterly Market Size by Manufacturers, 2019 VS 2020

3.2 Global Ketorolac Factory Price by Manufacturers

3.3 Location of Key Manufacturers Ketorolac Manufacturing Factories and Area Served

3.4 Date of Key Manufacturers Enter into Ketorolac Market

3.5 Key Manufacturers Ketorolac Product Offered

3.6 Mergers & Acquisitions, Expansion Plans

4 Impact of Covid-19 on Ketorolac Segments, By Type

4.1 Introduction

1.4.1 Tables

1.4.2 Injection

1.4.3 Other

4.2 By Type, Global Ketorolac Market Size, 2019-2021

4.2.1 By Type, Global Ketorolac Market Size by Type, 2020-2021

4.2.2 By Type, Global Ketorolac Price, 2020-2021

5 Impact of Covid-19 on Ketorolac Segments, By Application

5.1 Overview

5.5.1 Medical Uses

5.5.2 Chemistry Uses

5.5.3 Other

5.2 By Application, Global Ketorolac Market Size, 2019-2021

5.2.1 By Application, Global Ketorolac Market Size by Application, 2019-2021

5.2.2 By Application, Global Ketorolac Price, 2020-2021

6 Geographic Analysis

6.1 Introduction

6.2 North America

6.2.1 Macroeconomic Indicators of US

6.2.2 US

6.2.3 Canada

6.3 Europe

6.3.1 Macroeconomic Indicators of Europe

6.3.2 Germany

6.3.3 France

6.3.4 UK

6.3.5 Italy

6.4 Asia-Pacific

6.4.1 Macroeconomic Indicators of Asia-Pacific

6.4.2 China

6.4.3 Japan

6.4.4 South Korea

6.4.5 India

6.4.6 ASEAN

6.5 Rest of World

6.5.1 Latin America

6.5.2 Middle East and Africa

7 Company Profiles

7.1 Allergan

7.1.1 Allergan Business Overview

7.1.2 Allergan Ketorolac Quarterly Production and Revenue, 2020

7.1.3 Allergan Ketorolac Product Introduction

7.1.4 Allergan Response to COVID-19 and Related Developments

7.2 DeepCare Health

7.2.1 DeepCare Health Business Overview

7.2.2 DeepCare Health Ketorolac Quarterly Production and Revenue, 2020

7.2.3 DeepCare Health Ketorolac Product Introduction

7.2.4 DeepCare Health Response to COVID-19 and Related Developments

7.3 Cadila

7.3.1 Cadila Business Overview

7.3.2 Cadila Ketorolac Quarterly Production and Revenue, 2020

7.3.3 Cadila Ketorolac Product Introduction

7.3.4 Cadila Response to COVID-19 and Related Developments

7.4 FDC

7.4.1 FDC Business Overview

7.4.2 FDC Ketorolac Quarterly Production and Revenue, 2020

7.4.3 FDC Ketorolac Product Introduction

7.4.4 FDC Response to COVID-19 and Related Developments

7.5 Intas Laboratories

7.5.1 Intas Laboratories Business Overview

7.5.2 Intas Laboratories Ketorolac Quarterly Production and Revenue, 2020

7.5.3 Intas Laboratories Ketorolac Product Introduction

7.5.4 Intas Laboratories Response to COVID-19 and Related Developments

7.6 Gufic Chem

7.6.1 Gufic Chem Business Overview

7.6.2 Gufic Chem Ketorolac Quarterly Production and Revenue, 2020

7.6.3 Gufic Chem Ketorolac Product Introduction

7.6.4 Gufic Chem Response to COVID-19 and Related Developments

7.7 Ranbaxy

7.7.1 Ranbaxy Business Overview

7.7.2 Ranbaxy Ketorolac Quarterly Production and Revenue, 2020

7.7.3 Ranbaxy Ketorolac Product Introduction

7.7.4 Ranbaxy Response to COVID-19 and Related Developments

7.8 Adley Formulation

7.8.1 Adley Formulation Business Overview

7.8.2 Adley Formulation Ketorolac Quarterly Production and Revenue, 2020

7.8.3 Adley Formulation Ketorolac Product Introduction

7.8.4 Adley Formulation Response to COVID-19 and Related Developments

7.9 Neon Laboratories

7.9.1 Neon Laboratories Business Overview

7.9.2 Neon Laboratories Ketorolac Quarterly Production and Revenue, 2020

7.9.3 Neon Laboratories Ketorolac Product Introduction

7.9.4 Neon Laboratories Response to COVID-19 and Related Developments

7.10 Sun Pharmaceutical Industries

7.10.1 Sun Pharmaceutical Industries Business Overview

7.10.2 Sun Pharmaceutical Industries Ketorolac Quarterly Production and Revenue, 2020

7.10.3 Sun Pharmaceutical Industries Ketorolac Product Introduction

7.10.4 Sun Pharmaceutical Industries Response to COVID-19 and Related Developments

7.11 Cipla

7.11.1 Cipla Business Overview

7.11.2 Cipla Ketorolac Quarterly Production and Revenue, 2020

7.11.3 Cipla Ketorolac Product Introduction

7.11.4 Cipla Response to COVID-19 and Related Developments

7.12 Dallas Pharmaceuticals

7.12.1 Dallas Pharmaceuticals Business Overview

7.12.2 Dallas Pharmaceuticals Ketorolac Quarterly Production and Revenue, 2020

7.12.3 Dallas Pharmaceuticals Ketorolac Product Introduction

7.12.4 Dallas Pharmaceuticals Response to COVID-19 and Related Developments

7.13 Nicholas Piramal India

7.13.1 Nicholas Piramal India Business Overview

7.13.2 Nicholas Piramal India Ketorolac Quarterly Production and Revenue, 2020

7.13.3 Nicholas Piramal India Ketorolac Product Introduction

7.13.4 Nicholas Piramal India Response to COVID-19 and Related Developments

7.14 AHPL

7.14.1 AHPL Business Overview

7.14.2 AHPL Ketorolac Quarterly Production and Revenue, 2020

7.14.3 AHPL Ketorolac Product Introduction

7.14.4 AHPL Response to COVID-19 and Related Developments

8 Supply Chain and Sales Channels Analysis

8.1 Ketorolac Supply Chain Analysis

8.1.1 Ketorolac Supply Chain Analysis

8.1.2 Covid-19 Impact on Ketorolac Supply Chain

8.2 Distribution Channels Analysis

8.2.1 Ketorolac Distribution Channels

8.2.2 Covid-19 Impact on Ketorolac Distribution Channels

8.2.3 Ketorolac Distributors

8.3 Ketorolac Customers

9 Key Findings

10 Appendix

10.1 About Us

10.2 Disclaimer

Table 1. Overview of the World Economic Outlook Projections

Table 2. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)

Table 3. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 4. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 5. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 6. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 7. Covid-19 Impact: Global Major Government Policy

Table 8. The Covid-19 Impact on Ketorolac Assessment

Table 9. COVID-19 Impact: Ketorolac Market Trends

Table 10. COVID-19 Impact Global Ketorolac Market Size

Table 11. Global Ketorolac Market Size Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (K MT)

Table 12. Global Ketorolac Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026, (USD/MT)

Table 13. Global Ketorolac Quarterly Market Size, 2020 (US$ Million) & (K MT)

Table 14. Global Ketorolac Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (US$ Million)

Table 15. Global Ketorolac Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (K MT)

Table 16. Global Ketorolac Market Growth Drivers

Table 17. Global Ketorolac Market Restraints

Table 18. Global Ketorolac Market Opportunities

Table 19. Global Ketorolac Market Challenges

Table 20. Key Manufacturers Ketorolac Quarterly Revenue, 2019 VS 2020 (US$ Million)

Table 21. Top Manufacturers, Ketorolac Market Size, 2019 (K MT) & (US$ Million)

Table 22. Ketorolac Factory Price by Manufacturers 2020 (USD/MT)

Table 23. Location of Key Manufacturers Ketorolac Manufacturing Plants

Table 24. Key Manufacturers Ketorolac Market Served

Table 25. Date of Key Manufacturers Enter into Ketorolac Market

Table 26. Key Manufacturers Ketorolac Product Type

Table 27. Mergers & Acquisitions, Expansion Plans

Table 28. Global Ketorolac Market Size by Type, 2020, (US$ Million)

Table 29. Global Ketorolac Market Size by Type, 2020 (K MT)

Table 30. Global Ketorolac Price: by Type, 2020-2021 (USD/MT)

Table 31. Global Ketorolac Market Size by Application: 2020-2021 (US$ Million)

Table 32. Global Ketorolac Market Size by Application, 2020-2021 (K MT)

Table 33. Global Ketorolac Price: by Application, 2020-2021 (USD/MT)

Table 34. Global Ketorolac Market Size by Region, 2019-2021 (US$ Million)

Table 35. Global Ketorolac Market Size by Region, 2019-2021 (K MT)

Table 36. By Country, North America Ketorolac Market Size, 2019-2021 (US$ Million)

Table 37. By Country, North America Ketorolac Market Size, 2019-2021 (K MT)

Table 38. US Ketorolac Market Size, 2019-2021 (US$ Million) & (K MT)

Table 39. Canada Ketorolac Market Size, 2019-2021 (US$ Million) & (K MT)

Table 40. Macroeconomic Indicators of Europe (Germany, France, UK and Italy)

Table 41. By Country, Europe Ketorolac Market Size, 2019-2021 (US$ Million)

Table 42. By Country, Europe Ketorolac Market Size, 2019-2021 (K MT)

Table 43. Germany Ketorolac Market Size, 2019-2021 (US$ Million) & (K MT)

Table 44. France Ketorolac Market Size, 2019-2021 (US$ Million) & (K MT)

Table 45. UK Ketorolac Market Size, 2019-2021 (US$ Million) & (K MT)

Table 46. Italy Ketorolac Market Size, 2019-2021 (US$ Million) & (K MT)

Table 47. Macroeconomic Indicators of Asia-Pacific (China, Japan, South Korea, India and ASEAN)

Table 48. By Region, Asia-Pacific Ketorolac Market Size, 2019-2021 (US$ Million)

Table 49. By Region, Asia-Pacific Ketorolac Market Size, 2019-2021 (K MT)

Table 50. China Ketorolac Market Size, 2019-2021 (US$ Million) & (K MT)

Table 51. Japan Ketorolac Market Size, 2019-2021 (US$ Million) & (K MT)

Table 52. South Korea Ketorolac Market Size, 2019-2021 (US$ Million) & (K MT)

Table 53. India Ketorolac Market Size, 2019-2021 (US$ Million) & (K MT)

Table 54. ASEAN Ketorolac Market Size, 2019-2021 (US$ Million) & (K MT)

Table 55. Latin America Ketorolac Market Size, 2019-2021 (US$ Million) & (K MT)

Table 56. Middle East and Africa Ketorolac Market Size, 2019-2021 (US$ Million) & (K MT)

Table 57. Allergan Business Overview

Table 58. Allergan Ketorolac Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 59. Allergan Ketorolac Product

Table 60. Allergan Response to COVID-19 and Related Developments

Table 61. DeepCare Health Business Overview

Table 62. DeepCare Health Ketorolac Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 63. DeepCare Health Ketorolac Product

Table 64. DeepCare Health Response to COVID-19 and Related Developments

Table 65. Cadila Business Overview

Table 66. Cadila Ketorolac Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 67. Cadila Ketorolac Product

Table 68. Cadila Response to COVID-19 and Related Developments

Table 69. FDC Business Overview

Table 70. FDC Ketorolac Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 71. FDC Ketorolac Product

Table 72. FDC Response to COVID-19 and Related Developments

Table 73. Intas Laboratories Business Overview

Table 74. Intas Laboratories Ketorolac Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 75. Intas Laboratories Ketorolac Product

Table 76. Intas Laboratories Response to COVID-19 and Related Developments

Table 77. Gufic Chem Business Overview

Table 78. Gufic Chem Ketorolac Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 79. Gufic Chem Ketorolac Product

Table 80. Gufic Chem Response to COVID-19 and Related Developments

Table 81. Ranbaxy Business Overview

Table 82. Ranbaxy Ketorolac Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 83. Ranbaxy Ketorolac Product

Table 84. Ranbaxy Response to COVID-19 and Related Developments

Table 85. Adley Formulation Business Overview

Table 86. Adley Formulation Ketorolac Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 87. Adley Formulation Ketorolac Product

Table 88. Adley Formulation Response to COVID-19 and Related Developments

Table 89. Neon Laboratories Business Overview

Table 90. Neon Laboratories Ketorolac Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 91. Neon Laboratories Ketorolac Product

Table 92. Neon Laboratories Response to COVID-19 and Related Developments

Table 93. Sun Pharmaceutical Industries Business Overview

Table 94. Sun Pharmaceutical Industries Ketorolac Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 95. Sun Pharmaceutical Industries Ketorolac Product

Table 96. Sun Pharmaceutical Industries Response to COVID-19 and Related Developments

Table 97. Cipla Business Overview

Table 98. Cipla Ketorolac Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 99. Cipla Ketorolac Product

Table 100. Cipla Response to COVID-19 and Related Developments

Table 101. Dallas Pharmaceuticals Business Overview

Table 102. Dallas Pharmaceuticals Ketorolac Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 103. Dallas Pharmaceuticals Ketorolac Product

Table 104. Dallas Pharmaceuticals Response to COVID-19 and Related Developments

Table 105. Nicholas Piramal India Business Overview

Table 106. Nicholas Piramal India Ketorolac Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 107. Nicholas Piramal India Ketorolac Product

Table 108. Nicholas Piramal India Response to COVID-19 and Related Developments

Table 109. AHPL Business Overview

Table 110. AHPL Ketorolac Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 111. AHPL Ketorolac Product

Table 112. AHPL Response to COVID-19 and Related Developments

Table 113. Ketorolac Distributors List

Table 114. Ketorolac Customers List

Table 115. Covid-19 Impact on Ketorolac Customers

List of Figures

Figure 1. Ketorolac Product Picture

Figure 2. Ketorolac Market Segmentation

Figure 3. Research Objectives

Figure 4. Research Process

Figure 5. Data Triangulation

Figure 6. Research Approach

Figure 7. Commodity Prices-Metals Price Indices

Figure 8. Commodity Prices- Precious Metal Price Indices

Figure 9. Commodity Prices- Agricultural Raw Material Price Indices

Figure 10. Commodity Prices- Food and Beverage Price Indices

Figure 11. Commodity Prices- Fertilizer Price Indices

Figure 12. Commodity Prices- Energy Price Indices

Figure 13. G20+: Economic Policy Responses to COVID-19

Figure 14. Global Ketorolac Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (US$ Million)

Figure 15. Global Ketorolac Market Size, Pre-COVID-19 and Post- COVID-19, Year-over-Year Growth Rate, 2015-2026 (%)

Figure 16. Global Ketorolac Market Size, Quarterly Growth, 2020-2021 (%)

Figure 17. Global Ketorolac Market Size, Market Share by Type, 2019 VS 2020 (%)

Figure 18. Global Ketorolac Market Size, Market Share by Application, 2019 VS 2020 (%)

Figure 19. Global Ketorolac Market Size Market Share by Region, 2019 VS 2020 (%)

Figure 20. United States Composite PMI and GDP

Figure 21. Eurozone Composite PMI and GDP

Figure 22. Eurozone Core v. Periphery PMI Output Indices

Figure 23. Core v. Periphery PMI Employment Indices

Figure 24. UK Composite PMI and GDP

Figure 25. Caixin China Composite Output Index

Figure 26. Caixin China General Services Business Activity Index

Figure 27. Japan Composite Output Index

Figure 28. South Korea Manufacturing PMI

Figure 29. India Composite Output Index

Figure 30. ASEAN Manufacturing PMI

Figure 31. By Region, Asia-Pacific Ketorolac Market Size Market Share, 2019-2021